The role of CD147 in the invasiveness of follicular thyroid carcinoma cells

Thyroid

Volumn 22, Issue 4, 2012, Pages 383-394

  Omi, Yoko ^a   Shibata, Noriyuki ^a   Okamoto, Takahiro ^a   Obara, Takao ^a   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CD147 ANTIGEN; EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; WORTMANNIN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CARCINOMA CELL; CELL ACTIVITY; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RNA INTERFERENCE; THYROID FOLLICULAR CARCINOMA;

ADENOMA; ADOLESCENT; ADULT; AGED; ANTIGENS, CD147; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; FEMALE; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84859305234     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0426     Document Type: Article

References (33)

1. Sobrinho Simõ es M, Asa SL, Kroll TG, Nikiforov Y, DeLellis R, Farid P, Kitamura Y, Noguchi SU, Eng C Harach HR, Williams ED, Schneider AB, Fagin JA, Ghossein RA, Mazzaferri EL, LiVolsi V, Chan JKC, Baloch Z, Clark OH 2004 Follicular carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO Classification of Tumours. Pathology and Genetics. Tumours of Endocrine Organs. IARC Press, Lyon, pp 67-72.
2. Nabeshima K, Inoue T, Shimano Y, Sameshima T 2002 Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52:255-264. (Pubitemid 34587810)
3. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM 2000 Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149. (Pubitemid 30123793)
4. Nagase H, Woessner JF Jr. 1999 Matrix metalloproteinases. J Biol Chem 274:21491-21494.
5. Cho Mar K, Eimoto T, Tateyama H, Arai Y, Fujiyoshi Y, Hamaguchi M 2006 Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions. Hisopathology 48:286-294.
6. Kraiem Z, Korem S 2000 Matrix metalloproteinase and the thyroid. Thyroid 10:1061-1069.
7. Vincenti MP, Brinckerhoff CE 2007 Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression can MMPs be good for you? J Cell Physiol 213:355-364. (Pubitemid 47509713)
8. Biswas C 1982 Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 109: 1026-1034. (Pubitemid 13149714)
9. Iacono KT, Brown AL, Greene MI, Saouaf SJ 2007 CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 83:283-295. (Pubitemid 350087035)
10. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M 2006 Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56:359-367. (Pubitemid 43886799)
11. Kanekura T, Chen X, Kanazaki T 2002 Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 99:520-528. (Pubitemid 34461604)
12. Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN 2003 Over expression of extracellular matrix metalloproteinase inducer in multi-drug resistant cancer cells.Mol Cancer Res 1:420-427. (Pubitemid 36459252)
13. Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S 2000 Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 157:177-184. (Pubitemid 30629029)
14. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C 1997 Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272:24-27. (Pubitemid 27021117)
15. Tang Y, Kesavan P, Nakada MT, Yan L 2004 Tumor-stroma interaction: positive feed back regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2:73-80. (Pubitemid 38250423)
16. Kataoka H, DeCastro R, Zucker S, Biswas C 1993 Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72 kDa gelatinase. Cancer Res 53:3154-3158. (Pubitemid 23210328)
17. Muraoka K, Nabeshima K, Murayama T, Biswas C, Koono M 1993 Enhanced expression of a tumor cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers. Int J Cancer 55:19-26. (Pubitemid 23261700)
18. Caudroy S, Polette M, Tournier JM, Burlet H, Toole B, Zucker S, Birembaut P 1999 Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem 47:1575-1580.
19. Polette M, Gilles C, Marchand V, Lorenzato M, Toole B, Tournier JM, Zucker S, Birembaut P 1997 Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem 45: 703-710.
20. Bordador LC, Li X, Toole B, Chen B, Regezi J, Zardi L, Hu Y, Ramos DM 2000 Expression of EMMPRIN by oral squamous cell carcinoma. Int J Cancer 85:347-352. (Pubitemid 30030407)
21. Marionnet C, Lalou C, Mollier K, Chazal M, Delestaing G, Compan D, Verola O, Vilmer C, Cuminet J, Dubertret L, Basset-Séguin N 2003 Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development. Oncogene 29:3500-3505. (Pubitemid 36713748)
22. Ishibashi Y, Matsumoto T, Niwa M, Suzuki Y, Omura N, Hanyu N, Nakada K, Yanaga K, Yamada K, Ohkawa K, Kawakami M, Urashima M 2004 CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 101:1994-2000. (Pubitemid 39425374)
23. Aratake Y, Nomura H, Kotani T, Marutsuka K, Kobayashi K, Kuma K, Miyauchi A, Okayama A, Tamura K 2006 Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol 125: 399-406. (Pubitemid 43327709)
24. Aratake Y, Marutsuka K, Kiyoyama K, Kuribayashi K, Miyamoto T, Yakushiji K, Ohno S, Miyake Y, Sakaguchi T, Kobayashi TK, Okayama A, Tamura K, Ohno E 2009 EMMPRIN (CD147) expression and differentiation of papillary thyroid carcinoma: implications for immunocytochemistry in FNA cytology. Cytopathol 21:103-110.
25. Tan H, Ye K, Wang Z, Tang H 2008 CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma. Transl Res 152:143-149.
26. Thorns C, Feller AC, Merz H 2002 EMMPRIN (CD147) is expressed in Hodgkin's lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases. Anticancer Res 22:1983-1986. (Pubitemid 34857013)
27. Nabeshima K, Suzumiya J, Nagano M, Ohshima K, Toole BP, Tamura K, Iwasaki H, Kikuchi M 2004 Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 202:341-351. (Pubitemid 38325244)
28. Nabeshima K, Iwasaki H, Nishio J, Koga K, Shishime M, Kikuchi M 2006 Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumours: emmprin and membrane type (MT) 1-MMP expressions are associated with malignant potential. Anticancer Res 26:1359-1367.
29. Sapan CV, Lundblad RL, Price NC 1999 Colorimetric protein assay techniques. Biotechnol Appl Biochem 29:99-108. (Pubitemid 29178908)
30. Menashi S, Serova M, Ma L, Vignot S, Mourah S, Calvo F 2003 Regulation of extracellular matrixproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 63: 7575-7580. (Pubitemid 37466675)
31. Hoelting T, Tezelman S, Siperstein AE, Duh QY, Clark OH 1993 Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation. Biochem Biophys Res Comm 3:1230-1236. (Pubitemid 23290286)
32. Yeh MW, Rougier JP, Park JW, Duh QY, Wong M, Werb Z, Clark OH 2006 Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. Endocr Relat Cancer 13: 1173-1183. (Pubitemid 46212571)
33. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J, Basbaum C 2004 The microvesicle as a vehicle for EMMPRIN in tumorstromal interactions. Oncogene 23:956-963. (Pubitemid 38250941)